WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004032825) USE OF 2,3 ALKYLCARBONYLOXYBENZOIC ACIDS IN THE TREATMENT OF ANTHRAX
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/032825    International Application No.:    PCT/US2002/035056
Publication Date: 22.04.2004 International Filing Date: 31.10.2002
Chapter 2 Demand Filed:    30.05.2003    
IPC:
A61K 9/00 (2006.01), A61K 31/225 (2006.01), A61K 31/496 (2006.01), A61K 31/545 (2006.01), A61K 31/65 (2006.01), A61K 31/704 (2006.01), A61K 38/48 (2006.01)
Applicants: ADVANCED LIFE SCIENCES, INC. [US/US]; Suite 200, 1005 Internationale Parkway, Woodridge, IL 60517 (US)
Inventors: STEC, Karen, J.; (US)
Agent: HOSTER, Jeffrey, M.; 13 Woodland Drive, Lemont, IL 60439 (US)
Priority Data:
60/336,006 02.11.2001 US
Title (EN) USE OF 2,3 ALKYLCARBONYLOXYBENZOIC ACIDS IN THE TREATMENT OF ANTHRAX
(FR) UTILISATION D'ACIDES 2,3 ALKYLCARBONYLOXYBENZOIQUES POUR LE TRAITEMENT DU CHARBON
Abstract: front page image
(EN)A method for treating inhalation anthrax is disclosed. The inventive method comprises the use of 2,3-alkylcarbonyloxybenzoic acid and salts thereof in the prevention and treatment of lung damage caused by Bacillus anthracis and toxins produced by the bacterium. The 2,3-alkylcarbonyloxybenzoic acid may be used alone or in combination with other therapeutic agents such as antibiotics.
(FR)L'invention concerne une méthode permettant de traiter le charbon pulmonaire. Cette méthode comprend l'administration d'acide 2,3-alkylcarbonyloxybenzoïque et de sels de ce dernier pour la prévention et le traitement des atteintes pulmonaires causées par <i>Bacillus anthracis </i> et par les toxines produites par cette bactérie. L'acide 2,3-alkylcarbonyloxybenzoïque peut être utilisé seul ou combiné à d'autres agents thérapeutiques tels que des antibiotiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)